Evidence map›Paper›PMID 41970902›Full record

ArticleACS omega2026

Search for Inhibitors against Inflammatory Responses of Microglia in a Meroterpenoid Library Constructed by Synthetic-Biological Manipulation of Biosynthetic Pathways.

Kanako Takahashi, Zhiyang Quan, Yukari Shigemoto-Mogami, Bei-Bei Zhang, Tomohiko Ohwada, Ikuro Abe, Takayoshi Awakawa, Kaoru Sato

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kanako TakahashiLaboratory of Neuropharmacology, Division of Pharmacology, National Institute of Health Sciences, Kanagawa 210-9501, Japan.
Zhiyang QuanRIKEN, Center for Sustainable Resource Science, Saitama 351-0198, Japan.
Yukari Shigemoto-MogamiLaboratory of Neuropharmacology, Division of Pharmacology, National Institute of Health Sciences, Kanagawa 210-9501, Japan.
Bei-Bei ZhangLaboratory of Natural Products Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033,Japan.
Tomohiko OhwadaLaboratory of Organic and Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033,Japan.ORCID https://orcid.org/0000-0001-5390-0203
Ikuro AbeLaboratory of Natural Products Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033,Japan.ORCID https://orcid.org/0000-0002-3640-888X
Takayoshi AwakawaRIKEN, Center for Sustainable Resource Science, Saitama 351-0198, Japan.ORCID https://orcid.org/0000-0003-2575-3175
Kaoru SatoLaboratory of Neuropharmacology, Division of Pharmacology, National Institute of Health Sciences, Kanagawa 210-9501, Japan.ORCID https://orcid.org/0009-0000-6793-3719

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglia are the resident immune cells of the central nervous system. Activation-induced proinflammatory responses of microglia are associated with various neurodegenerative diseases, and therefore, inhibitors against microglial inflammatory responses are promising candidates for the treatment of those diseases as well as efficient tools to investigate the involvement of microglia in the pathologies. Here, we focused on meroterpenoids (MPs), which are hybrid compounds of a terpenoid and a nonterpenoid moiety such as a polyketide, phenol, alkaloid, or amino acid. We constructed a structurally diverse library of MPs by expressing combinations of enzymes catalyzing various biosynthetic steps, including polyketide synthesis, prenyl transfer, prenyl chain epoxidation, terpene cyclization, and postcyclization tailoring reactions, in

Identifiers

PMID41970902
PMCPMC13063036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.